For Moderna COVID-19 vaccine, a single COVID-19 vaccine booster dose is recommended greater than or equal to 6 months after completion of an mRNA primary series, in the same risk groups for whom CDC recommended a booster of Pfizer-BioNTech, under FDA’s Emergency Use Authorization. The Moderna booster dose is a smaller 50 microgram dose. • CDC recommends the following groups should receive boosters: people 65 years and older and residents in long-term care settings should receive a 50-mcg booster shot of Moderna’s COVID-19 vaccine at least 6 months after their Moderna primary series, o people aged 50–64 years with underlying medical conditions should receive a 50- mcg booster shot of Moderna’s COVID-19 vaccine at least 6 months after their Moderna primary series. • Additionally, CDC recommends the following groups may be considered for boosters. people aged 18–49 years with underlying medical conditions may receive a 50- mcg booster shot of Moderna’s COVID-19 vaccine at least 6 months after their Moderna primary series, based on their individual benefits and risks. People aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a 50- mcg booster shot of Moderna’s COVID-19 vaccine at least 6 months after their Moderna primary series, based on their individual benefits and risks. For Janssen (Johnson and Johnson) COVID-19 vaccine, a single COVID-19 vaccine booster dose is recommended for persons aged 18 years and older, greater than or equal to 2 months after receipt of the initial Janssen dose, under the FDA’s Emergency Use Authorization. As a reminder, the ACIP recommended a booster shot of Pfizer-BioNTech’s COVID-19 vaccine September 24, 2021. Those recommendations are as follows: • CDC recommends the following groups should receive boosters: people 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, people aged 50–64 years with underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series. • Additionally, CDC recommends the following groups may be considered for boosters. people aged 18–49 years with underlying medical conditions may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks, and people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer BioNTech primary series.
Copyright © 2021 City of Christopher - All Rights Reserved
Designed by Jim Taylor - Powered by GoDaddy